🇺🇸 Ocular Therapeutix, Inc.
Forum topic · OCUL · Company page: financials, ownership and filings
Join the discussion on Ocular Therapeutix, Inc.
Loading…
Results announced on 9 November 2026
Ocular Therapeutix, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $13 million (down 11% from a year earlier) and a net loss of $95 million.
Insider trading in October 2026
Directors and officers of Ocular Therapeutix, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 3 insiders sold shares worth about $234,419 in 3 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 171 funds hold $575 million
171 mutual funds in 2 countries hold shares of Ocular Therapeutix, Inc. worth $575 million, about 28.4% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 116 funds added shares and 39 sold; on balance they bought $39 million. Share splits are not counted as trading.